Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma
The goal of this study is to determine the utility of cerebrospinal fluid (CSF) cell-free DNA (cfDNA) as a prognostic biomarker in glioblastoma (GBM).
Glioblastoma
DIAGNOSTIC_TEST: Lumber Puncture
Overall Survival, Overall survival will be calculated as the time from pathological diagnosis to the date of death due to any cause (prior to analysis cut-off) or last follow-up, 6 months
The goal of this study is to determine the utility of cerebrospinal fluid (CSF) cell-free DNA (cfDNA) as a prognostic biomarker in glioblastoma (GBM).